Inventor

ALMSTETTER MICHAEL

DE12 patents

⚠️ This page may combine multiple inventors who share the name “ALMSTETTER MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ORIGENIS GMBH

4 patents

US10000482B2Jun 19, 2018

Kinase inhibitors

ORIGENIS GMBH2 citations68

US9637491B2May 2, 2017

Pyrazolo[4,3-D]pyrimidines as kinase inhibitors

ORIGENIS GMBH2 citations68

US10752624B2Aug 25, 2020

Kinase inhibitors

ORIGENIS GMBH0 citations47

US12384788B2Aug 12, 2025

1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune disease

ORIGENIS GMBH0 citations44

NOVARTIS AG

2 patents

US7504436B2Mar 17, 2009

Bioisosteres of actinonin

NOVARTIS AG8 citations82

US7932255B2Apr 26, 2011

2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators

NOVARTIS AG1 citations45

THORMANN MICHAEL

2 patents

US9802937B2Oct 31, 2017

Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors

THORMANN MICHAEL9 citations79

US9499535B2Nov 22, 2016

Kinase inhibitors

THORMANN MICHAEL2 citations57

COTTAREL GUILLAUME

1 patent

US9155792B2Oct 13, 2015

RecA inhibitors with antibiotic activity, compositions and methods of use

COTTAREL GUILLAUME16 citations75

DEMUTH HANS-ULRICH

1 patent

US8889709B2Nov 18, 2014

Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions

DEMUTH HANS-ULRICH4 citations68

HEISER ULRICH

1 patent

US8962860B2Feb 24, 2015

Inhibitors of glutaminyl cyclase

HEISER ULRICH0 citations48

PROBIODRUG AG

1 patent

US7728146B2Jun 1, 2010

Enzyme inhibitors

PROBIODRUG AG0 citations39